David GROHEUX, MD, PHD, is a French nuclear physician with expertise in oncology. He is married and has three children. He practices at the Saint-Louis hospital in PARIS, where he is also a researcher member of the “physiopathology of breast cancer” team, INSERM, UMR 1342, Université Paris Cité. This multidisciplinary team seeks to better understand the development of breast cancer in order to better treat it. David GROHEUX has mainly worked on the role of FDG PET/CT in the initial staging of breast cancer and in the early assessment of neoadjuvant treatment. He has participated in around 80 publications appended on Pub-Med, of which around 50 as first author and 10 as last author. Most of his publications concern PET scans and breast cancer. He has contributed to 7 books chapters. He is a member of several editorial boards. He has reviewed around a hundred articles for scientific journals, most of them international. He has contributed to several national and international guidelines on FDG-PET/CT and breast cancer. For the past fifteen years, he has taught at the inter-university diploma in breast diseases at Université Paris Cité. In parallel with his research activity in Paris, he participated to develop PET imaging in two departments in France, La Charente-Maritime and les Deux-Sèvres, by installing the first PET-Scan centers in these departments.